Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

OCT are Expanding the Use of the CTMS Platform with Flex Databases

Published: Thursday, August 29, 2013
Last Updated: Thursday, August 29, 2013
Bookmark and Share
Expansion to implement the workflow management tool.

Flex Databases has announced that OCT are expanding the use of the Flex CTMS platform to implement the workflow management tool.

OCT is a full-service Contract Research Organization (CRO) founded in 2005 in St. Petersburg. OCT are operating in Russia, Ukraine, Belarus, Latvia, Lithuania, and Estonia.

"We have been working with Flex since March 2013", said Dmitry Sharov, President of OCT. "Offering a PSA platform rather than a stand-alone CTMS product, the Flex system has the tools to redefine what it means to be an efficient service organization. With every step we take, we can feel the technology lifting the weight off our shoulders. The workflow tool allows us to standardize every process, from a monitoring visit to hiring a new employee, while giving senior management full visibility on the status of each workflow."

"We are happy to see OCT leveraging the full potential of our platform", said Timur Galimov, Technical Director of Flex Databases. "Workflows are probably the most important tool in our toolbox. Imagine a virtual automated assembly line. This is what the workflow tool does for a process - once activated, it starts engaging people in the process, passing the task from one person to another, running checks and triggering alarm if something doesn't go as planned. Running a complex business process without a workflow tool is like building a car without an assembly line - it can be done, but it takes twice the time and costs twice the money."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos